With an advanced, proprietary pipeline of truly innovative antibacterial agents, Biovertis is uniquely positioned in a growth market with substantial commercial opportunity. Biovertis strives to develop its programs to their full potential while retaining substantial value within the Company. The Company expects to attract global and / or regional co-development partnerships with pharmaceutical or biotechnology companies at commercially attractive terms.
To learn more about partnering opportunities please contact Erich Felber (info@biovertis.com)
